Fair Value Calculator Fair Value Calculator
EN DE

NMSRESRC (NMSRESRC) Fair Value & Analysis

IN · Market cap ₹180M

N NMSRESRC NMSRESRC · BSE
Price₹86.87
Fair Value₹61.42
Upside-29.3%
Quality50/100
Watch NMSRESRC for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹42.99 – ₹79.84

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price +5.3% over the past month.

Price vs Fair Value (12 months)

₹98.89 ₹51.60 Fair Value ₹61.42 Jul 2025 Jul 2026

12‑month range ₹51.60 – ₹98.89 · fair‑value band ₹42.99 – ₹79.84 · the ₹86.87 price screens above the ₹61.42 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

NMSRESRC (NMSRESRC) currently trades at ₹86.87, while our model-based Fair Value estimate is ₹61.42 — implying the stock looks roughly 29.3% overvalued today. We read business quality at 50/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, NMSRESRC generated revenue of ₹115M at a net margin of 5.9%. Revenue declined 49.7% year over year. It earns a return on equity of 44.7%. Net debt stands at ₹44.1M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹42.99 (bear case) to ₹79.84 (bull case); at ₹86.87, the current price sits above that range. The share trades about 16% below its 52-week high and 77% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹115M
Revenue growth (YoY) -49.7%
Net margin 5.9%
Return on equity 44.7%
Free cash flow −₹175M FY2025
P/E ratio 25.9
More key figures
Operating margin 18.2%
EPS (TTM) ₹2.31
EPS growth (YoY) -16.1%
Net debt ₹44.1M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

NMSRESRC reported revenue of ₹185M in FY2025 versus ₹102M in FY2021, a compound +16.1%/yr. Reported net income was ₹4.1M in FY2025, compounding −6.8%/yr from FY2021.

Revenue +16.1%/yr
FY21 ₹102M
FY22 ₹27.4M
FY23 ₹65.6M
FY24 ₹248M
FY25 ₹185M
Net income −6.8%/yr
FY21 ₹5.4M
FY22 ₹233K
FY23 ₹2.8M
FY24 ₹3.3M
FY25 ₹4.1M

Is NMSRESRC fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "NMSRESRC Fair Value". https://www.fairvalue-calculator.com/stock/NMSRESRC

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is NMSRESRC (NMSRESRC) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹61.42 versus a price of ₹86.87 — about −29% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NMSRESRC?
Our model-based fair value for NMSRESRC is ₹61.42 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹86.87.
What is the quality score of NMSRESRC?
NMSRESRC has a Quality Score of 50/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of NMSRESRC (NMSRESRC)?
NMSRESRC reported trailing-twelve-month revenue of about ₹115M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of NMSRESRC?
The net profit margin of NMSRESRC is about 5.9%, meaning it keeps roughly 5.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.